Advertisement

The Dressing

  • Giovanni Cannarozzo
  • Steven Paul Nisticò
  • Keyvan Nouri
  • Mario Sannino
Chapter
  • 106 Downloads

Abstract

Wound healing is the ability of the body to repair injured tissue. Wounds can go through healing in two different ways: the first and second intention. Wounds must be cleansed before any topical treatment. Cleansing ensures a correct evaluation, allows the removal of debris and residues of the previous dressing, and dilutes the bacterial load. Appropriate dressing should take into account several factors, such as wound type, location, size, presence of infection, and type and quantity of exudate. The choice of dressing directly affects tissue repair.

Notes

Acknowledgments

Special thanks to Dr. Luigi Bennardo, Dr. Federica Tamburi and Dr. Giovanna Galdo for their precious contribution in editing and revising this chapter.

References

  1. 1.
    Goldman MP, Roberts TL, et al. Optimizing wound healing in the face after laser abrasion. J Am Acad Dermatol. 2002;46:399–407.  https://doi.org/10.1067/mjd.2002.118358.CrossRefPubMedGoogle Scholar
  2. 2.
    Ruiz-Esparza J, Barba Gomez JM, Gomez de la Torre OL. Wound care after laser skin resurfacing: a combination of open and closed methods using a new polyethylene mask. Dermatol Surg. 1998;24:79–81. PMID: 9464294.CrossRefGoogle Scholar
  3. 3.
    Suarez M, Fulton JE. A novel occlusive dressing for skin resurfacing. Dermatol Surg. 1998;24:567–70. PMID: 9598013.CrossRefGoogle Scholar
  4. 4.
    Nistico S, Tamburi F, Bennardo L, Dastoli S, Schipani G, Caro G, Fortuna MC, Rossi A. Treatment of telogen effluvium using a dietary supplement containing Boswellia serrata, Curcuma longa, and Vitis vinifera: results of an observational study. Dermatol Ther. 2019;32(3):e12842.  https://doi.org/10.1111/dth.12842.CrossRefGoogle Scholar
  5. 5.
    Muscoli C, Lauro F, Dagostino C, Ilari S, Giancotti LA, Gliozzi M, Costa N, Carresi C, Musolino V, Casale F, Ventrice D, Oliverio E, Palma E, Nisticò S, Procopio A, Mollace V. Olea Europea-derived phenolic products attenuate antinociceptive morphine tolerance: an innovative strategic approach to treat cancer pain. J Biol Regul Homeost Agents. 2014;28(1):105–16.Google Scholar
  6. 6.
    Chimento SM, Newland M, Ricotti C, Nistico S, Romanelli P. A pilot study to determine the safety and efficacy of monochromatic excimer light in the treatment of vitiligo. J Drugs Dermatol. 2008;7(3):258–63. PMID: 18380207.PubMedPubMedCentralGoogle Scholar
  7. 7.
    Nisticò S, Saraceno R, Capriotti E, De Felice C, Chimenti S. Efficacy of monochromatic excimer light (308 nm) for the treatment of atopic dermatitis in adults and children. Photomed Laser Surg. 2008;26(1):14–8.  https://doi.org/10.1089/pho.2017.2116.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Chiricozzi A, Pitocco R, Saraceno R, Giunta A, Nisticò S, Chimenti S. New topical treatments for psoriasis. Expert Opin Pharmacother. 2014;15(4):461–70.CrossRefGoogle Scholar
  9. 9.
    Chiricozzi A, Saraceno R, Nisticò S, Giunta A, Cannizzaro MV, Chimenti S. Complete resolution of erythrodermic psoriasis in a HIV and HCV patient unresponsive to anti-psoriatic treatments after highly active anti-retroviral therapy (ritonavir, atazanavir, emtricitabine, tenofovir). Dermatology. 2012;225(4):333–7.CrossRefGoogle Scholar
  10. 10.
    Specchio F, Saraceno R, Chimenti S, Nisticò S. Management of non-melanoma skin cancer in solid organ transplant recipients. Int J Immunopathol Pharmacol. 2014;27(1):21–4.  https://doi.org/10.1177/039463201402700104.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Specchio F, Carboni I, Chimenti S, Tamburi F, Nisticò S. Cutaneous manifestations in patients with chronic renal failure on hemodialysis. Int J Immunopathol Pharmacol. 2014;27(1):1–4.  https://doi.org/10.1177/039463201402700101.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Bottoni U, Tiriolo R, Pullano S, Dastoli S, Amoruso G, Nistico S, Fiorillo A. Infrared saliva analysis of psoriatic and diabetic patients: similarities in protein components. IEEE Trans Biomed Eng. 2016;63(2):379–84.  https://doi.org/10.1109/TBME.2015.2458967.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Terrinoni A, Codispoti A, Serra V, Bruno E, Didona B, Paradisi M, Nisticò S, Campione E, Napolitano B, Diluvio L, Melino G. Connexin 26 (GJB2) mutations as a cause of the KID syndrome with hearing loss. Biochem Biophys Res Commun. 2010;395(1):25–30.  https://doi.org/10.1016/j.bbrc.2010.03.098.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Paolillo N, Piccirilli S, Giardina E, Rispoli V, Colica C, Nisticò S. Effects of paraquat and capsaicin on the expression of genes related to inflammatory, immune responses and cell death in immortalized human HaCat keratinocytes. Int J Immunopathol Pharmacol. 2011;24(4):861–8.  https://doi.org/10.1177/039463201102400405.CrossRefGoogle Scholar
  15. 15.
    Martin P. Wound healing-aiming for perfect skin regeneration. Science. 1997;276:75–81.  https://doi.org/10.1126/science.276.5309.75.CrossRefGoogle Scholar
  16. 16.
    Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med. 1999;341:738–46.  https://doi.org/10.1056/NEJM199909023411006.CrossRefPubMedGoogle Scholar
  17. 17.
    Cannarozzo G, Sannino M, Tamburi F, Chiricozzi A, Saraceno A, Morini C, Nisticò S. Deep pulse fractional CO2 laser combined with a radio-frequency system: results of a case series. Photomed Laser Surg. 2014;32(7):409–12.  https://doi.org/10.1089/pho.2014.3733.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Filippini M, Del Duca E, Negosanti F, Bonciani D, Negosanti L, Sannino M, Cannarozzo G, Nisticò S. Fractional CO2 laser: from skin rejuvenation to vulvo-vaginal reshaping. Photomed Laser Surg. 2017;35(3):171–5. ISSN: 1549-5418.  https://doi.org/10.1089/pho.2016.4173.CrossRefGoogle Scholar
  19. 19.
    Mercuri SR, Brianti P, Dattola A, Bennardo L, Silvestri M, Schipani G, Nisticò SP. CO2 laser and photodynamic therapy: study of efficacy in periocular BCC. Dermatol Ther. 2018;31(4):e12616.  https://doi.org/10.1111/dth.12616.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Hermanson A, Dalsgaard CJ, Bjorklund H, Lindblom U. Sensory reinnervation and sensibility after superficial skin wounds in human patients. Neurosci Lett. 1987;74:377–82.  https://doi.org/10.1016/0304-3940(87)90327-2.CrossRefPubMedGoogle Scholar
  21. 21.
    Graf RM, Bernardes A, Auerswald A, Noronha L. Full-face laser resurfacing and rhytidectomy. Aesthet Plast Surg. 1999;23:101–6. PMID: 10227909.CrossRefGoogle Scholar
  22. 22.
    Geronemus R, Alster T, Brandt F, et al. Table talk: common questions about laser resurfacing. Dermatol Surg. 1998;24:123–4.Google Scholar
  23. 23.
    Wanitphakdeedecha R, Phuardchantuk R, Manuskiatti W. The use of sunscreen starting on the first day after ablative fractional skin resurfacing. J Eur Acad Dermatol Venereol. 2014;28(11):1522–8.  https://doi.org/10.1111/jdv.12332.CrossRefPubMedGoogle Scholar
  24. 24.
    Cannarozzo G, Morini C, Sannino M, Campolmi P, Nisticò SP. Postablative laser management: mupirocin 2% vs. gentamicin 0.1% ointment. Dermatol Exp. 2014;16:1–2.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Giovanni Cannarozzo
    • 1
  • Steven Paul Nisticò
    • 2
  • Keyvan Nouri
    • 3
  • Mario Sannino
    • 1
  1. 1.Department of DermatologyUniversity of Rome Tor VergataRomeItaly
  2. 2.Department of Health ScienceMagna Graecia UniversityCatanzaroItaly
  3. 3.Department of Dermatology and Cutaneous SurgeryUniversity of Miami Leonard M. Miller School of MedicineMiamiUSA

Personalised recommendations